Detection of CTX-M type Extended Spectrum Beta Lactamase genes among gram-negative clinical strains isolated from a tertiary care hospital, Mangalore (Karnataka, S.India)  by Sinha, N. & Shenoy, S.
e l of In
T
F
S
D
T
R
D
g
t
N
1
2
s
g
e
G
p
f
t
T
m
K
A
t
b
d
a
f
w
C
o
3
C
g
t
T
u
5
t
g
g
a
a
t
p
h432 15th ICID Abstracts / International Journa
ype: Poster Presentation
inal Abstract Number: 56.057
ession: Antibiotics
ate: Saturday, June 16, 2012
ime: 12:45-14:15
oom: Poster & Exhibition Area
etection of CTX-M type Extended Spectrum Beta Lactamase
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CHACHA NEHRU BAL CHIKITSALAY, New Delhi, DELHI, India
Kasturba Medical College, Mangalore, Karnataka, India
Background: The high incidence of ESBL producing strainswith
carce prior documentation of the prevalent ESBL genes in Man-
alore propulgated this study. It was carried out to evaluate the
xistence of the CTX-M type genes in ESBL producing strains of
ram negative clinical isolates from Government tertiary care hos-
ital, Mangalore, Karnataka (India).
Methods: A total of 116 samples (129 isolates) were collected
rom patients hospitalised in various wards of Government ter-
iary care hospital, Mangalore from August 2008 to August 2009.
he isolates obtainedwere identiﬁed and conﬁrmedusing standard
icrobiological and biochemical tests. Escherichia coli ATCC 25922,
lebsiella pneumoniae ATCC 700603 and Pseudomonas aeruginosa
TCC 27853 were the control strains used. Production of ESBL was
ested for all isolates by phenotypic conﬁrmatory test using com-
ination disk containing third-generation cephalosporin antibiotic
isk alone (Ceftazidime 30g) and in combination with clavulanic
cid (Ceftazidime + Clavulanic acid 30/10g). A total of 75 isolates
rom the family Enterobacteriaceae, and Pseudomonas spp which
ere phenotypically conﬁrmed ESBL producers were evaluated for
TX-M type genes by performingconventional PCR.
Results: 58.1% of the clinical isolates were ESBL producers. In
ur study ESBL production ranged from 40% in Escherichia coli,
4.7% in Klebsiella spp, 16% in Pseudomonas spp, 4% to 1.3% each in
itrobacter spp and Proteus spp. In addition to resistance to third
eneration cephalosporins, most of these isolates showed resis-
ance to sulfonamides, gentamicin, ciproﬂoxacin and aztreonam.
he ESBL producing strains when subjected to conventional PCR
sing standard primers showed that out of the 75 isolates tested
1 were positive for blaCTX-M.
Conclusion: From the above results, it can be concluded that
here is a high prevalence of ESBL producing isolates with CTX-M
enes among patients in Government tertiary care hospital, Man-
alore. These ﬁndings show that in our setting, hospitals provide
favourable environment for the resistant organisms to emerge
nd disseminate. If this situation prevails there will be difﬁcul-
ies in therapeutic intervention of infections which could only be
revented by continuous surveillance and proper use of antibiotics.
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Antimicrobial susceptibility and resistant integron of Klebsiella
oxytoca isolates in Russia
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Background: Klebsiella oxytoca infection is a recent problem
in pediatrics (resistant strains are often isolated from neonates
and young children with antibiotic-associated diarrhea or intesti-
nal dysbiosis) and in general surgery. There are no current surveys
on this pathogen in Russia and this work provides useful compar-
ative data on antimicrobial pattern and molecular epidemiology
of isolates recovered from the hospitalized and non-hospitalized
patients.
Methods: K. oxytoca isolates were recovered in Perm city (the
Urals, Russia) between February and October 2011 from inpa-
tients admitted to neonatal units, ICUs and surgery wards (total
11) and from outpatients with diagnosis of intestinal dysbiosis
(total 21). Colonization and infection were determined accord-
ing to published criteria for nosocomial infection. Susceptibility
to extended-spectrum cephalosporins, carbapenems, aminogly-
cosides, and ﬂuoroquinolones was determined by the standard
disk diffusion method according to the CLSI protocols. Extended-
spectrum beta-lactamase (ESBL) phenotype was conﬁrmed using
the double-disk synergy method with disks containing ceftazidime
(30g) and cefotaxime (30g) either alone or in combination with
clavulanic acid (20/10 g). Class 1 integron components were
ampliﬁed by PCR and sequenced.
Results: In this survey a total of 32 K. oxytoca isolates were
recovered from stool and urine samples collected in hospitalized
and non-hospitalized neonates and young children (total 20) and
adults (total 5). Seven isolateswere recovered fromsurgerywounds
of adult patients admitted to ICUs, general and cardiovascular
surgery (CS)wards. ESBLproductionwasdetectableonly in twoepi-
demiologically unrelated multi-drug resistant isolates recovered
frompatients admitted to ICUandCS. The latter isolate had sul-type
class1 integronwithgenecassettes arrayofdfrA17andaadA5under
control of hybrid (v.1) promoter. This genetic construct is widely
presented among Enterobacteriaceae and affects resistance toward
trimethoprim and streptomycin/spectinomycin. ESBL-positive iso-
lateswere susceptible to carbapenems and ﬂuoroquinolones. None
multi-drug resistant, ESBL-producing and/or integron-positive iso-
lateswere recovered from stool and urine of neonates, children and
adults.
Conclusion: High-risk cohort for infection caused by K. oxy-
toca comprises the postoperative patients which may be affected
by multidrug-resistant ESBL-producing strains. Even in specialized
wards with low infection rates, integron-positive strains may con-
tribute to the spread of antimicrobial resistance determinants.
http://dx.doi.org/10.1016/j.ijid.2012.05.607
